Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Stealth BioTherapeutics Corp    MITO

STEALTH BIOTHERAPEUTICS CORP

(MITO)
  Report  
Delayed Quote. Delayed Nasdaq - 07/17 03:57:16 pm
11 USD   -1.08%
05/16STEALTH BIOTHERAPEUTICS : Reports First Quarter 2019 Financial Results and Recent Business Highlights
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/11/2019 07/12/2019 07/15/2019 07/16/2019 07/17/2019 Date
12.12(c) 11.7(c) 11.12(c) 11.12(c) 11(c) Last
134 4 803 4 366 569 1 825 Volume
+3.15% -3.47% -4.96% 0.00% -1.08% Change
More quotes
Financials (USD)
Sales 2019 -
EBIT 2019 -80,4 M
Net income 2019 -105 M
Debt 2019 -
Yield 2019 -
Sales 2020 17,2 M
EBIT 2020 -127 M
Net income 2020 -110 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -29,1x
P/E ratio 2020 -30,0x
Capi. / Sales2019 infx
Capi. / Sales2020 22,4x
Capitalization 385 M
More Financials
Company
More about the company
Surperformance© ratings of Stealth BioTherapeutics Co
Trading Rating : Investor Rating : -
More Ratings
Latest news on STEALTH BIOTHERAPEUTICS CO
05/16STEALTH BIOTHERAPEUTICS : Reports First Quarter 2019 Financial Results and Recen..
AQ
05/02STEALTH BIOTHERAPEUTICS : Announces Positive Results for Elamipretide in Ophthal..
AQ
04/18STEALTH BIOTHERAPEUTICS : Announces Positive Results for Elamipretide in Barth S..
AQ
02/18STEALTH BIOTHERAPEUTICS : Bios IPO Raises $78M for Clinical Tests of Mitochondri..
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
07/17GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
07/16As steep patent cliff looms, Shionogi moves to develop its own U.S. sales sta..
RE
07/16GSK's two-drug HIV Dovato treatment meets main goal in study
RE
07/15Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
07/15Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
More sector news : Biotechnology & Medical Research - NEC
Chart STEALTH BIOTHERAPEUTICS CORP
Duration : Period :
Stealth BioTherapeutics Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STEALTH BIOTHERAPEUTICS CO
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 27,60  $
Last Close Price 11,00  $
Spread / Highest target 218%
Spread / Average Target 151%
Spread / Lowest Target 45,5%
EPS Revisions
Managers
NameTitle
Irene P. McCarthy Chief Executive Officer & Executive Director
Lok Chung Chan Chairman
Daniel E. Geffken Chief Financial Officer
Mark J. Bamberger Chief Scientific Officer
Sai Sing Cheung Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
STEALTH BIOTHERAPEUTICS CORP0.00%385
IQVIA HOLDINGS INC34.30%31 409
LONZA GROUP32.31%25 111
CELLTRION, INC.--.--%20 827
INCYTE CORPORATION26.17%17 419
EXACT SCIENCES CORPORATION84.37%15 001